KDR and glioblastoma: A summary of the anti-angiogenic agents proposed for treatment of glioblastoma, and a visual illustration of where several of these anti-VEGFR inhibitors act on the VEGF signaling pathway are shown in Table 1 and Figure 1, respectively.